Flublok trivalent northern hemisphere (influenza a virus a/west virginia/30/2022 (h1n1) recombinant hemagglutinin antigen, influenza a virus a/massachusetts/18/2022 (h3n2) recombinant hemagglutinin antigen, and influenza b virus b/austria/1359417/2021 recombinant hemagglutinin antigen)
(INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/MASSACHUSETTS/18/2022 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN)Sanofi Pasteur Inc.
Usage: Flublok is a vaccine indicated for active immunization against influenza A virus subtypes and influenza type B virus. It is approved for use in individuals aged 18 years and older to prevent influenza-related diseases.